Issue 1/1999
Content (15 Articles)
Improved Technique for Establishing Short Term Human Brain Tumor Cultures
Maxine A. Farr-Jones, Ian F. Parney, Kenneth C. Petruk
Sequential Imaging and Volumetric Analysis of an Intracerebral C6 Glioma by Means of a Clinical MRI System
Frank A. Raila, Alfred P. Bowles, Eddie Perkins, Allen Terrell
Expression of PECAM-1/CD31 Isoforms in Human Brain Gliomas
Frédérique Aroca, Wanda Renaud, Catherine Bartoli, Corine Bouvier-Labit, Dominique Figarella-Branger
Suppression of TGF-β1 in Human Gliomas by Retroviral Gene Transfection Enhances Susceptibility to LAK Cells
Ryuya Yamanaka, Ryuichi Tanaka, Seiichi Yoshida, Takafumi Saitoh, Kazuyuki Fujita, Hirofumi Naganuma
Presurgical Serum Albumin Levels Predict Survival Time from Glioblastoma Multiforme
Judith A. Schwartzbaum, Priya Lal, Wendi Evanoff, Sandra Mamrak, Allan Yates, Gene H. Barnett, Joseph Goodman, James L. Fisher
Topotecan for the Treatment of Recurrent or Progressive Central Nervous System Tumors – A Pediatric Oncology Group Phase II Study
Richard P. Kadota, Clinton F. Stewart, Marianna Horn, John F. Kuttesch, Peter C. Burger, James L. Kepner, Larry E. Kun, Henry S. Friedman, Richard L. Heideman
Blood Flow and Metabolism of Oligodendrogliomas: A Positron Emission Tomography Study with Kinetic Analysis of 18F-fluorodeoxyglucose
Katsuyoshi Mineura, Hitoshi Shioya, Masayoshi Kowada, Toshihide Ogawa, Jun Hatazawa, Kazuo Uemura
Simultaneous Presentation of Atypical Teratoid/Rhabdoid Tumor in Siblings
F. Proust, A. Laquerriere, B. Costantin, M.M. Ruchoux, J.P. Vannier, P. Fréger
Salvage Chemotherapy with Taxol for Recurrent Anaplastic Astrocytomas
Marc C. Chamberlain, Patty Kormanik
Gossypol Treatment of Recurrent Adult Malignant Gliomas
Peter Bushunow, Marcus M. Reidenberg, John Wasenko, Jeffrey Winfield, Beverly Lorenzo, Sheila Lemke, Benjamin Himpler, Robert Corona, Thomas Coyle
Use of Different Outcome Measures in Randomised Studies of Malignant Glioma can Significantly Alter the Interpretation of Time to Progression: Reanalysis of the MRC BR2 Study
Jeremy Chataway, Sally Stenning, Norman Bleehen, Robert Grant